Primary Record
carbacyclin
- In stock
- 7,673 g
- Purity
- 99.4 %
- CAS
- 69552-46-1
Compound Identifiers & Properties
- CAS
- 69552-46-1
- PubChem CID
- 6436393
- SMILES
- CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O
- Canonical SMILES
- CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O
Names & Synonyms
- carbacyclin
- Carboprostacyclin
- Carbaprostacyclin
- Carba pgx
- Carbacycline
- 6a-Carba-pgi2
- carba-prostacyclin
- 6,9-Methano pgi2
- 6,9-Methano-pgi2
- Carbocyclic PGI2
- cPGI
- 6,9-Methanoprostaglandin I2
- 69552-46-1
- RefChem:123649
- Spectrum5_001983
- (5E)-6a-Carba-prostaglandin I2
- 6a-Carba-prostaglandin I2
- 9alpha-Deoxy-9alpha-methylene-pgi2
- AC1O5LL2
- BSPBio_001573
- XZFRIPGNUQRGPI-WBQKLGIQSA-N
- BML1-G09
- CHEMBL435828
- DTXSID801346736
- orb1710160
- SCHEMBL1479163
- Carbacyclin (Carbocyclic PGI2)
- Carbacyclin, >=90% (HPLC)
- (5E)-6a-Carbaprostaglandin 12
- CHEBI:190588
- DTXCID201775422
- HMS1361O15
- HMS1791O15
- HMS1989O15
- HMS3402O15
- C21H34O4
- ZINC4215181
- AKOS040732707
- C21-H34-O4
- CID6436393
- (5Z)-6A-CARBAPROSTAGLANDIN I2
- IDI1_034043
- NCGC00161296-01
- NCGC00161296-02
- NCGC00161296-03
- NCGC00161296-04
- DB-223189
- HY-112322
- J342.371I
- LS-176759
- CS-0045198
- (5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid
- C530152
- SR-05000002106
- U-55185
- SR-05000002106-2
- BRD-K27499107-001-02-6
- BRD-K27499107-001-03-4
- BRD-K27499107-001-05-9
- (5E)-5-[(3aS,4S,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid
- Pentanoic acid, 5-(hexahydro-5-hydroxy-4-(3-hydroxy-1-octenyl)-2(1H)-pentalenylidene)-, (3aS-(2E,3aalpha,4alpha(1E,3R*),5beta,6aalpha))-
- (E)-5-((3aS,4R,5R,6aS)-5-Hydroxy-4-((S,E)-3-hydroxyoct-1-en-1-yl)hexahydropentalen-2(1H)-ylidene)pentanoic acid
- Pentanoic acid, 5-((3aS,4R,5R,6aS)-hexahydro-5-hydroxy-4-((1E,3S)-3-hydroxy-1-octenyl)-2(1H)-pentalenylidene)-, (5E)-
- Pentanoic acid,5-[(3aS,4R,5R,6aS)-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-1-octenyl]-2(1H)-pentalenylidene]-,(5E)-
- 6,9.alpha.-Methylene-11.alpha.,15S-dihydroxy-prosta-5E,13E-dien-1-oic acid
- (5E)-5-[(3abeta,6abeta)-4beta-[(1E,3S)-3-Hydroxy-1-octenyl]-5alpha-hydroxyoctahydropentalene-2-ylidene]valeric acid
- [3aS-[2E,3aa,4a(1E,3R*),5ss,6aa]]-5-[Hexahydro-5-hydroxy-4-(3-hydroxy-1-octenyl)-2(1H)-pentalenylidene]-pentanoic Acid; (5E)-5-[(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-1-octenyl]-2(1H)-pentalenylidene]pentanoic Acid; (+)-Carbacyclin; (5E)-6a-Carbaprostaglandin I2; 5(E)-Carbacyclin; Carba-PGI2; Carbacyclin; Carbaprostacyclin; Carboprostacyclin;
- 5-[(1beta,3E,5beta,6R)-6beta-[(1E,3S)-3-Hydroxy-1-octenyl]-7alpha-hydroxybicyclo[3.3.0]octane-3-ylidene]pentanoic acid
- 5-[(2E,3aS,4R,5R,6aS)-5-hydroxy-4-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-octahydropentalen-2-ylidene]pentanoic acid
- 5-[(2E,3aS,5R,6abeta)-Octahydro-5alpha-hydroxy-4beta-[(1E,3S)-3-hydroxy-1-octenyl]pentalen-2-ylidene]pentanoic acid
- 69609-77-4